Please Wait...

Christopher P. Orlando

Translation skills

Main profile

Christopher P. Orlando
Christopher P. Orlando
Executive Vice President, General Counsel & Chief Compliance Officer

Chris is a senior legal executive with over 23 years of experience, including serving as a strategic counsel to boards-of-directors and senior management on clinical trial matters. Prior to joining Bioclinica, Chris was Vice President and General Counsel for the BioPharma Services Division (BSD) at Thermo Fisher Scientific where he oversaw all legal matters globally for the clinical trial businesses. His responsibilities included managing commercial transactions, contracting, claims and litigation, data privacy, global trade compliance (import / export), regulatory compliance, and risk management for BSD. Prior to this, Chris was Senior Vice President, General Counsel and Corporate Secretary at Comprehensive NeuroScience, Inc., which provided clinical trials, care management technology, and medical education services to life science companies. Chris earned a bachelor's degree in Pharmacy from St. John's University College of Pharmacy and Allied Health. While practicing as a Registered Pharmacist in hospital and retail settings, he earned his law degree from St. John's University School of Law. Chris is a member of the bar in New York, New Jersey and Connecticut, and holds an in-house counsel license in the Commonwealth of Pennsylvania. He also is a member of the Association of Corporate Counsel and the International Association for Contract & Commercial Management.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (21 hours ago)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (Yesterday)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (6 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen